2 results
28/Apr/2025
DOI: 10.31744/einstein_journal/2025AO1343
Highlights ■ The molecular test according to the WHO classification of CNS tumors (gliomas) was performed in 100% (172) of patients. ■ Education on chemotherapy and informed consent for patients with brain tumors was carried out for 100% (130) of the patients who had an indication for chemotherapy treatment. ■ Approximately 87% of the patients with gliomas underwent postoperative cranial MRI. ■ A multidisciplinary approach, including molecular testing, was used for 35% of patients with glioma. ■ Thromboembolic events after […]
Keywords: Brain neoplasms; Central nervous system neoplasms; Glioma; Length of stay; Magnetic resonance imaging; Meningioma; Patient outcome assessment; Postoperative complications; Quality improvement; Quality Indicators, Health Care
09/Nov/2022
DOI: 10.31744/einstein_journal/2022AO0104
ABSTRACT Objective To evaluate whether there is a significant difference in somatostatin analog uptake in meningiomas treated or not with radiation therapy. Methods A cross-sectional study was performed comparing measurements of somatostatin analog (68Ga-DOTATATE) uptake in two independent groups of ten patients each – one consisting of patients with meningiomas previously treated with radiation therapy and another comprising patients who had never been submitted to radiation therapy. All patients underwent PET/CT and MRI scans in an interval shorter than 24 […]
Keywords: Meningioma; Positron-emission tomography; Radiotherapy; Receptors; somatostatin